IRIS
ROSSI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.900
AS - Asia 3.806
EU - Europa 3.184
SA - Sud America 555
Continente sconosciuto - Info sul continente non disponibili 214
AF - Africa 163
OC - Oceania 6
Totale 13.828
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.751
CN - Cina 1.775
SG - Singapore 839
IE - Irlanda 703
VN - Vietnam 416
BR - Brasile 414
RU - Federazione Russa 397
HK - Hong Kong 394
DE - Germania 388
FI - Finlandia 355
UA - Ucraina 331
IT - Italia 320
FR - Francia 182
GB - Regno Unito 177
SE - Svezia 129
ZA - Sudafrica 96
IN - India 90
CA - Canada 70
BE - Belgio 54
MX - Messico 50
BD - Bangladesh 48
AR - Argentina 45
JP - Giappone 34
TR - Turchia 33
IQ - Iraq 30
CO - Colombia 29
PL - Polonia 29
PK - Pakistan 22
ES - Italia 21
MA - Marocco 20
NL - Olanda 20
ID - Indonesia 19
EC - Ecuador 18
AT - Austria 17
CL - Cile 13
CZ - Repubblica Ceca 13
PH - Filippine 12
IR - Iran 11
MY - Malesia 11
DZ - Algeria 9
SA - Arabia Saudita 9
AL - Albania 8
BO - Bolivia 8
VE - Venezuela 8
EG - Egitto 7
LT - Lituania 7
PY - Paraguay 7
UZ - Uzbekistan 7
AU - Australia 6
KE - Kenya 6
LB - Libano 6
RO - Romania 6
AZ - Azerbaigian 5
CR - Costa Rica 5
ET - Etiopia 5
PE - Perù 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
GR - Grecia 4
JO - Giordania 4
KG - Kirghizistan 4
NP - Nepal 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
BH - Bahrain 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
EU - Europa 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
IL - Israele 3
KR - Corea 3
NG - Nigeria 3
PS - Palestinian Territory 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BG - Bulgaria 2
CG - Congo 2
JM - Giamaica 2
MM - Myanmar 2
PT - Portogallo 2
SI - Slovenia 2
SR - Suriname 2
SV - El Salvador 2
TH - Thailandia 2
TM - Turkmenistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CH - Svizzera 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GL - Groenlandia 1
GY - Guiana 1
HR - Croazia 1
Totale 13.600
Salva come PNG Salva come JPEG
Città #
Dublin 702
Chandler 657
San Jose 586
Dallas 565
Singapore 469
Ashburn 439
Beijing 419
Jacksonville 385
Hong Kong 383
Nanjing 323
Council Bluffs 236
Ann Arbor 235
Boardman 181
Los Angeles 156
Munich 133
Nanchang 127
Ho Chi Minh City 123
Helsinki 122
Princeton 112
Hanoi 111
Lawrence 109
Shenyang 105
Lauterbourg 102
Wilmington 100
Changsha 97
Medford 95
New York 92
Johannesburg 89
Hebei 81
Shanghai 74
Pavia 70
Moscow 63
Jiaxing 62
Woodbridge 62
Tianjin 60
Hangzhou 58
Turku 57
Orem 56
Brussels 53
Santa Clara 53
Buffalo 52
Milan 52
São Paulo 49
Redondo Beach 44
Houston 30
Tokyo 28
Verona 28
Frankfurt am Main 27
Washington 26
Chennai 23
Chicago 23
Montreal 23
San Francisco 23
Atlanta 22
Seattle 22
Warsaw 22
Brooklyn 21
Da Nang 21
Denver 21
Dearborn 18
Haiphong 18
London 18
Rio de Janeiro 18
Falkenstein 17
Toronto 17
Auburn Hills 15
Stockholm 15
Baghdad 14
Fairfield 14
Mexico City 14
Norwalk 14
Nuremberg 14
Poplar 14
The Dalles 14
Ankara 13
Belo Horizonte 13
Dhaka 13
Brasília 12
Columbus 12
Kunming 12
Phoenix 12
Rome 12
Boston 11
Guangzhou 11
Medellín 11
San Giuliano Milanese 11
Buenos Aires 10
Hải Dương 10
Jinan 10
Mumbai 10
New Delhi 10
Santiago 10
Amsterdam 9
Biên Hòa 9
Bogotá 9
Des Moines 9
Istanbul 9
Ninh Bình 9
Piscataway 9
Vienna 9
Totale 9.068
Salva come PNG Salva come JPEG
Nome #
Combined antiresorptive and new anabolic drug approach in osteogenesis imperfecta zebrafish models 189
Kinetic and structural evidences on human prolidase pathological mutants suggest strategies for enzyme functional rescue 188
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 185
Adesion proteins in CHO cells. 173
A de novo G to T transversion in a pro-a1(I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain. 172
A Mn(II)-Mn(II) center in human prolidase 168
Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family. 164
Improved prolidase activity assay allowed enzyme kinetic characterization and faster prolidase deficiency diagnosis 162
Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta. 160
Cartilage histogenesis in a murine model of chondrodysplasia 159
A novel splicing mutation causes an undescribed type of analbuminemia. 157
Matrix disruptions, growth, and degradation of cartilage with impaired sulfation. 154
Stability and networks of hydrogen bonds of the collagen triple helical structure: influence of pH and chaotropic nature of three anions. 150
Diastrophic Dysplasia Sulfate Transporter (SLC26A2) Is Expressed in the Adrenal Cortex and Regulates Aldosterone Secretion. 150
Insights from a transgenic mouse model on the role of SLC26A2 in health and disease. 148
Comparative analysis of the expression of methionine sulfoxide reductase enzymes in human blood cells 147
Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation. 145
Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach 144
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation. 144
Partial rescue of biochemical parameters after hematopoietic stem cell transplantation in a patient with prolidase deficiency due to two novel PEPD mutations 142
Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta 142
Methionine sulfoxide reductase enzymes (Msr): a comparative analysis of the levels of expression in human blood cells 141
Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate 140
Alteration of proteoglycan sulfation affects bone growth and remodeling. 139
4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion 138
Altered cytoskeletal organization characterized lethal but not surviving Brtl+/- mice: insight on phenotypic variability in osteogenesis imperfecta 138
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 138
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 136
Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification 136
Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies. 135
Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship. 135
Interaction of decorin with CNBr peptides from collagens I and II. Evidence for multiple binding sites and essential lysyl residues in collagen 135
Role of the advanced glycation end products receptor in Crohn’s disease inflammation 134
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta. 133
The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta 131
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype 131
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy 131
N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia 130
Neutrophil granulocytes uniquely express, among human blood cells, high levels of Methionine-sulfoxide-reductase enzymes. 129
A novel mutation in the sulphate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia. 128
Fast screening of glycosaminoglycan disaccharides by fluorophore-assisted carbohydrate electrophoresis (FACE): applications to biologic samples and pharmaceutical formulations 128
Lack of prolidase causes a bone phenotype both in human and in mouse 127
Analbuminemia in a Swiss family is caused by a C --> T transition at nucleotide 4446 of the albumin gene. 126
Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations 124
Zebrafish Collagen Type I: Molecular and Biochemical Characterization of the Major Structural Protein in Bone and Skin 124
Self-aggregation of fibrillar collagens I and II involves lysine side chains. 124
Ultrastructural aspects of cartilage histogenesis in a model of chondrodysplasia 123
N-benzyloxycarbonyl-L-proline: an in vitro inhibitor of prolidase. 122
Early Fracture Healing is Delayed in the Col1a2 +/G610C Osteogenesis Imperfecta Murine Model 122
Anomalous cysteine in type I collagen. Localisation by chemical cleavage of the protein using 2-nitro-5-thiocyanobenzoic acid and by mismatch analysis of cDNA heteroduplexes. 121
Effect of the triterpenoid fraction of Centella asiatica on macromolecules of the connective matrix in human skin fibroblast cultures. 121
Use of capillary zone electrophoresis for analysis of imidodipeptides in urine of prolidase-deficient patients. 121
Optimization of a capillary electrophoretic method to detect and quantify the Gly-Pro dipeptide in complex matrices from long term cultured prolidase deficiency fibroblasts 120
Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype 120
Polyethylene Glycol-Poly-Lactide-co-Glycolide Block Copolymer-Based Nanoparticles as a Potential Tool for Off-Label Use of N-Acetylcysteine in the Treatment of Diastrophic Dysplasia 119
Stability of type I collagen peptide trimers. 115
Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta. 115
Knocking out TMEM38B in human foetal osteoblasts hFOB 1.19 by CRISPR/Cas9: A model for recessive OI type XIV 115
A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations 114
Bone cell differentiation and mineralization in wild-type and osteogenesis imperfecta zebrafish are compromised by per- and poly-fluoroalkyl substances (PFAS) 113
Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. 113
Novel nonsense mutation causes analbuminemia in a Moroccan family. 113
A nucleotide insertion and frameshift cause albumin Kenitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges. 113
Impaired proteoglycan glycosylation, elevated TGF-β signaling, and abnormal osteoblast differentiation as the basis for bone fragility in a mouse model for gerodermia osteodysplastica 113
A family of chondrodysplasias caused by mutations in the diastrophic dysplasia sulfate transporter gene and associated with impaired sulfation of proteoglycans. 112
In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knock-in murine model for classical, dominant osteogenesis imperfecta 112
Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling 108
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 107
Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis. 107
Chondroitin Sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1) Deficiency Results in a Mild Skeletal Dysplasia and Joint Laxity 107
The administration of exogenous HSP47 as a collagen-specific therapeutic approach 104
Type I collagen CNBr peptides: species and behavior in solution 104
Bone and connective tissue disorders caused by defects in glycosaminoglycan biosynthesis: a panoramic view 104
Molecular diagnosis of analbuminemia: A novel mutation identified in two amerindian and two Turkish families 101
Mucosal expression of the receptor for the advanced glycation end products (RAGE) in patients with inflammatory bowel disease (IBD) 101
Achondrogenesis type 1B is caused by mutations in the diastrophic dysplasia sulfate transporter gene 101
Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis. 101
EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and collagen expression in the exostoses. 99
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 99
Skeletal Dysplasias Caused by Sulfation Defects 96
Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta. 95
Analysis of proteoglycan synthesis and secretion in cell culture systems 95
Identification of potential non-invasive biomarkers in diastrophic dysplasia 94
Osteogenesis imperfecta and type I collagen mutations. A lethal variant caused by a Gly910->Ala substitution in the a1(I) chain. 93
Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for a Leu483Pro substitution in the diastrophic dysplasia sulfate transporter 93
Phenotypic characterization of immortalized chondrocytes from a desbuquois dysplasia type 1 mouse model: A tool for studying defects in glycosaminoglycan biosynthesis 93
FGF signalling regulates bone growth through autophagy 92
Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta. 91
FACE analysis as a fast and reliable methodology to monitor the sulfation and total amount of chondroitin sulfate in biological samples of clinical importance. 91
Targeting cellular stress in vitro improves osteoblast homeostasis, matrix collagen content and mineralization in two murine models of osteogenesis imperfecta 91
Diastrophic dysplasia sulfate transporter (DTDST) gene is not involved in pseudodiastrophic dysplasia 90
Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing 90
The receptor for the advanced glycation end products is overexpressed in the intestinal mucosa of patients with crohn’s disease 89
Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes 88
Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. 85
In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias 85
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 85
Phenotypic features of carbohydrate sulfotransferase 3 (CHST3) deficiency in 24 patients: congenital dislocations and vertebral changes as principal diagnostic features 85
CaMKII inhibition due to TRIC-B loss-of-function dysregulates SMAD signaling in osteogenesis imperfecta 84
Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis. 82
Totale 12.221
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.383
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022492 0 0 0 13 13 9 13 40 21 18 87 278
2022/20231.871 180 175 15 151 194 165 6 88 804 20 46 27
2023/2024664 90 141 25 48 63 155 15 40 9 24 28 26
2024/20252.095 54 133 61 61 84 92 88 99 542 62 297 522
2025/20264.849 363 536 560 492 529 225 867 265 435 371 121 85
2026/2027721 64 240 324 93 0 0 0 0 0 0 0 0
Totale 13.828